Balance Sheet
Cash Flow Statement
Beginning Cash BalanceCash from Financing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based CompensationShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Mangoceuticals (MGRX) Free Cash Flow (2023 - 2025)

Mangoceuticals (MGRX) has disclosed Free Cash Flow for 3 consecutive years, with -$1.1 million as the latest value for Q4 2025.

  • Quarterly Free Cash Flow rose 4.59% to -$1.1 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$5.9 million through Dec 2025, down 20.28% year-over-year, with the annual reading at -$5.9 million for FY2025, 20.28% down from the prior year.
  • Free Cash Flow hit -$1.1 million in Q4 2025 for Mangoceuticals, up from -$1.2 million in the prior quarter.
  • In the past five years, Free Cash Flow ranged from a high of -$991131.0 in Q1 2024 to a low of -$2.3 million in Q1 2025.
  • Historically, Free Cash Flow has averaged -$1.5 million across 3 years, with a median of -$1.4 million in 2024.
  • Biggest five-year swings in Free Cash Flow: skyrocketed 45.3% in 2024 and later crashed 129.51% in 2025.
  • Year by year, Free Cash Flow stood at -$1.7 million in 2023, then skyrocketed by 33.47% to -$1.1 million in 2024, then grew by 4.59% to -$1.1 million in 2025.
  • Business Quant data shows Free Cash Flow for MGRX at -$1.1 million in Q4 2025, -$1.2 million in Q3 2025, and -$1.3 million in Q2 2025.